Helen Morrison

Helen Morrison is the Director of Global Patient Safety at Amgen, bringing 25 years of global expertise in pharmacovigilance across clinical development and post-marketing environments. Currently serving as the Senior Director of the Periodic Reports Team at Eli Lilly and Company, Helen has previously led a global team of safety scientists at PPD and overseen periodic safety reporting as Global Safety Senior Manager at Amgen. Known for fostering cross-functional collaboration and delivering innovative solutions, Helen has demonstrated a strong commitment to safety and compliance throughout their career. They are also pursuing a short course in Large Language Models at the University of Cambridge.